Dr. Claudine Isaacs, MD
Claim this profileGeorgetown University
Studies Breast Cancer
Studies Tumors
12 reported clinical trials
30 drugs studied
Area of expertise
1Breast Cancer
Stage IV
ER positive
HER2 positive
2Tumors
ER positive
ER negative
HER2 positive
Affiliated Hospitals
Clinical Trials Claudine Isaacs, MD is currently running
Denosumab to Prevent Breast Cancer in Women With BRCA1 Mutation
for undefined
This phase III trial compares denosumab to placebo for the prevention of breast cancer in women with a BRCA1 germline mutation. A germline mutation is an inherited gene change which, in the BRCA1 gene, is associated with an increased risk of breast and other cancers. Denosumab is a monoclonal antibody that is used to treat bone loss in order to reduce the risk of bone fractures in healthy people, and to reduce new bone growths in cancer patients whose cancer has spread to their bones. Research has shown that denosumab may also reduce the risk of developing breast cancer in women carrying a BRCA1 germline mutation.
Recruiting1 award Phase 38 criteria
Personalized Adaptive Novel Agents
for Breast Cancer
This trial is testing new medicines along with regular cancer treatment to find the best combinations for breast cancer patients. It focuses on identifying which treatments work best based on specific cancer characteristics. Early signs of success are monitored using MRI scans and tests on blood and tissue samples.
Recruiting1 award Phase 216 criteria
More about Claudine Isaacs, MD
Clinical Trial Related3 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Claudine Isaacs, MD has experience with
- Palbociclib
- Avelumab
- Tucatinib
- Trastuzumab Deruxtecan
- Pathologic Evaluation Of Excised Tissue
- Oral Paclitaxel + Encequidar + Dostarlimab (TSR-042) + Carboplatin With Or Without Trastuzumab
Breakdown of trials Claudine Isaacs, MD has run
Breast Cancer
Tumors
Cancer
BRCA1
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Claudine Isaacs, MD specialize in?
Claudine Isaacs, MD focuses on Breast Cancer and Tumors. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are ER positive.
Is Claudine Isaacs, MD currently recruiting for clinical trials?
Yes, Claudine Isaacs, MD is currently recruiting for 3 clinical trials in Washington District of Columbia. If you're interested in participating, you should apply.
Are there any treatments that Claudine Isaacs, MD has studied deeply?
Yes, Claudine Isaacs, MD has studied treatments such as Palbociclib, Avelumab, Tucatinib.
What is the best way to schedule an appointment with Claudine Isaacs, MD?
Apply for one of the trials that Claudine Isaacs, MD is conducting.
What is the office address of Claudine Isaacs, MD?
The office of Claudine Isaacs, MD is located at: Georgetown University, Washington, District of Columbia 20007 United States. This is the address for their practice at the Georgetown University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.